The Value of Pancreatic Stone Protein in Predicting Acute Appendicitis

NCT01610193 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 245

Last updated 2013-08-23

No results posted yet for this study

Summary

PSP (Pancreatic Stone Protein) is a compound naturally produced mainly in the pancreas and the gut. There is evidence from experimental and clinical trials that the levels of PSP in the blood rise in the presence of inflammation or infection. What is not yet well known about PSP is whether it is superior to other established blood tests (e.g. WBC or CRP) in predicting appendicitis in patients that present at the emergency room with abdominal pain and a clinical suspicion of appendicitis.

Conditions

Interventions

PROCEDURE

Appendicectomy

Also known as appendectomy, surgical removal of the appendix. Laparoscopic (single or 4 port), McBurney's incision, mid-line laparotomy, laparoscopic converted to open.

Sponsors & Collaborators

  • Laikο General Hospital, Athens

    collaborator OTHER
  • University of Athens

    collaborator OTHER
  • Kantonsspital Münsterlingen

    collaborator OTHER
  • University of Zurich

    lead OTHER

Principal Investigators

  • Dimitri A Raptis, MD, MSc · University Hospital Zurich, Department of Surgery

  • Rolf Graf, PhD · University Hospital Zurich, Department of Surgery

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-12-31
Completion
2014-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01610193 on ClinicalTrials.gov